A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug ...

New research suggests that diabetes and weight-loss drugs known as GLP-1 receptor agonists may also help treat alcohol and ...

Because GLP-1 agonists seem to reduce patients’ desire for food, it isn’t surprising that they might also shrink or even ...

Preliminary study shows GLP-1 receptor agonists alter alcohol response, suggesting potential for reducing cravings and ...

Students have access to a wide range of substance abuse resources that include educational opportunities, skill development and intervention support, accompanied by regular programming promoting a ...

A small study found that drugs like Ozempic, Wegovy, and Mounjaro change the way the body processes alcohol, making it less ...

Popular weight loss drugs, like semaglutide (Ozempic, Wegovy) and liraglutide (Victoza), have transformed the way doctors treat diabetes and obesity. Now research suggests these meds — part of a class ...

A study has found that glucagon-like peptide-1 (GLP-1) class obesity treatments, such as ‘Wegovy,’ may slow the rate of alcohol absorption. By delaying alcohol absorption, they reportedly reduce ...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has announced it will review the use of medicines containing sodium oxybate, a drug used in narcolepsy, ...